Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | AORT | NPK |
|---|---|---|
| Price | $21.61 | $147.68 |
| Change today | ▼ 1.05% | ▼ 0.86% |
| Market cap | $1.05B | $1.05B |
| Return, 3 months | -10.4% | +18.2% |
| Return, year to date | -52.6% | +39.3% |
| Return, 1 year | -47.3% | +29.3% |
| P/E (TTM) | -360.2 | 24.7 |
| P/B | 2.4 | 2.6 |
| P/E percentile vs own 5y | 9th | 79th |
| Dividend yield | – | 0.68% |
| Revenue growth (YoY, latest qtr) | +11.3% | +21.7% |
| Net profit growth (YoY) | -1,104.5% | +207.9% |
| Gross margin | 64.4% | 16.5% |
| Operating margin | 2.9% | 9.3% |
| Net margin | -0.7% | 7.9% |
| Return on equity | -0.7% | 10.9% |
| Analyst target vs. price | +93.8% | +9.7% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 31 | 49 |
| 30-day volatility | 31.6% | 27.8% |
| Max drawdown, 1 year | -57.8% | -23.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
